Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...

A research team at the Max Planck Institute for Chemical Ecology has successfully combined single-cell RNA sequencing (scRNA-seq) and single-cell mass spectrometry (scMS) analysis on the same plant ...

People with Type 1 diabetes lose insulin-producing beta cells due to an autoimmune reaction, forcing lifelong dependence on ...

LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

A potential new therapy for diabetics has been discovered that could prove to be a major breakthrough in the management of type 2 diabetes. The latest research centers on a specific gene, SMOC1. In ...

Researchers demonstrated that pancreatic β cells from type 2 diabetes donors can partially regain glucose responsiveness when ...

(Reuters) -AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives ...

The company is gene editing crops to make our food supply more resilient to climate change. Climate change will make it increasingly difficult to grow crops across many parts of the world. Pairwise is ...

At the forum “Gene editing in agriculture - Strategic technology tied to a legal framework” held on October 18, Deputy Minister of Agriculture and Environment Phung Duc Tien emphasized that ...

For decades, synthetic biologists have been developing gene circuits that can be transferred into cells for applications such as reprogramming a stem cell into a neuron or generating a protein that ...

In a video shared on the social media platform X on Thursday, the investor shared his thoughts on the probe into Tesla. "I don't think that they're [NHTSA] going after Tesla per se," the investor said ...